Stability of Generic Versions of Gemcitabine Hydrochloride Preparation for Injection-Reference-Cited by-同舟云学术

Stability of Generic Versions of Gemcitabine Hydrochloride Preparation for Injection

Published:2015 Issue:8 Volume:41 Page:550-555
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Kuwahara Akiko¹,Minegaki Tetsuya²,Hamada Miki²,Wakabayashi Miki²,Asai Mayuri²,Ohnishi Yuki²,Fujimoto Misaki²,Kobatake Maki¹,Koyanagi Shiori¹,Sunami Hiroko¹,Takamatsu Misato¹,Watamoto Yukiko¹,Toyohara Tomoko¹,Tsujimoto Masayuki²,Kataoka Kazusaburo¹,Nishiguchi Kohshi²

Affiliation:

1. Educational Center for Clinical Pharmacy, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University

2. Department of Clinical Pharmacy, Kyoto Pharmaceutical University

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jjphcs/41/8/41_550/_pdf

Reference8 articles.

1. 1) Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, 1997, 15, 2403-2413.

2. 2) Oettle H, Progress in the knowledge and treatment of advanced pancreatic cancer: from benchside to bedside, Cancer Treat Rev, 2014, 40, 1039-1047.

3. 3) Vincent A, Herman J, Schulick R, Hruban RH, Goggins M, Pancreatic cancer, Lancet, 2011, 378, 607-620.

4. 4) de Sousa Cavalcante L, Monteiro G, Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer, Eur J Pharmacol, 2014, 741, 8-16.

5. 5) Anliker SL, McClure MS, Britton TC, Stephan EA, Maple SR, Cooke GG, Degradation chemistry of gemcitabine hydrochloride, a new antitumor agent, J Pharm Sci, 1994, 83, 716-719.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular Pain;Anticancer Research;2021-12-29

2. Liquid Formulation of Gemcitabine Increases Venous Pain in Patients With Cancer: A Retrospective Study;Clinical Therapeutics;2020-04

3. Effect of pH and Additives on the Compatibility between Vancomycin and Furosemide Injections;YAKUGAKU ZASSHI;2018-06-01